Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefuroxime PK/PD target attainment in adult ward patients with different renal function
2021-006860-26Phase 4Completed
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cefuroxime in bacterial disease, sponsored by Noordwest Ziekenhuisgroep. Primary endpoint: PK-PD target attainment in first 24 hours. Started Jan 2022; status: completed.
02
Drugs
cefuroxime
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2021-006860-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006860-26.